| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 45,005 | 40,713 | 33,680 | 25,458 | | Cost of Revenue | 10,771 | 9,751 | 8,054 | 6,033 | | | Gross Profit | 34,234 | 30,962 | 25,626 | 19,425 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,671 | 26,175 | 21,610 | 18,094 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,563 | 4,787 | 4,016 | 1,331 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23 | 41 | (35) | 18 | | Earnings Before Interest And Taxes | 5,586 | 4,828 | 3,981 | 1,349 | | Interest Expense | 40 | 69 | 5 | 207 | | Income Before Tax | 5,546 | 4,759 | 3,976 | 1,142 | | Income Tax Expense | 2,112 | 1,760 | 1,491 | 193 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,434 | 2,999 | 2,485 | 949 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,434 | 2,999 | 2,485 | 949 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,434 | $2,999 | $2,485 | $949 |
|
0.23% Nasdaq 
0.12%
Income Statement
